Home › Funds › Invesco › Invesco S&P 500 (R) Pure Value ETF
Fund family: Invesco · Filed by INVESCO EXCHANGE-TRADED FUND TRUST (CIK 1209466) · SEC series S000060792
Ticker: RPV (C000197608)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,606 with, 79 against, 14 abstentions (not counted as with management). Shareholder proposals: 25 FOR, 54 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Invesco’s manager page (413,145 ballot items across 270 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Invesco | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.2% | 1,592 | 94.5% | 357,245 |
| Backed environmental and social shareholder proposals at US companies | n/a | 27 | 3.1% | 5,987 |
Each ballot item this fund voted is set against the votes of the other Invesco funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Invesco funds on all 1,657 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 99.2% of this fund’s 1,699 such votes could be given a sector; the other 13 (0.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 423 | 13 | 3.1% |
| Consumer Discretionary | 291 | 21 | 7.2% |
| Health Care | 216 | 10 | 4.6% |
| Industrials | 185 | 9 | 4.9% |
| Energy | 165 | 6 | 3.6% |
| Consumer Staples | 153 | 6 | 3.9% |
| Utilities | 91 | 2 | 2.2% |
| Telecommunications | 81 | 8 | 9.9% |
| Technology | 49 | 4 | 8.2% |
| Real Estate | 19 | 0 | 0.0% |
| Basic Materials | 13 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,280 | 0 |
| Say-on-Pay | 127 | 0 |
| Audit-related | 121 | 0 |
| Corporate Governance | 71 | 44 |
| Compensation | 51 | 4 |
| Capital Structure | 13 | 0 |
| Environment or Climate | 12 | 12 |
| Other Social Issues | 9 | 9 |
| Extraordinary Transactions | 8 | 0 |
| Shareholder Rights and Defenses | 5 | 4 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| DuPont de Nemours, Inc. | May 21, 2026 | $81M | 13 | 0 |
| Centene Corporation | May 12, 2026 | $55M | 12 | 1 |
| Humana Inc. | April 16, 2026 | $50M | 14 | 1 |
| Molina Healthcare, Inc. | May 6, 2026 | $40M | 14 | 0 |
| Cardinal Health, Inc. | November 5, 2025 | $40M | 14 | 0 |
| Target Corporation | June 10, 2026 | $37M | 18 | 3 |
| Dow Inc. | April 9, 2026 | $37M | 16 | 0 |
| Phillips 66 | May 13, 2026 | $36M | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 12, 2026 | Centene Corporation | STOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. Shareholder proposal | Against | For |
| April 16, 2026 | Humana Inc. | The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposal | Against | For |
| May 7, 2026 | Archer-Daniels-Midland Company | Stockholder Proposal Regarding Issuance of a Report on Pesticide Use Data Reporting in Regenerative Agriculture Program Disclosures. Shareholder proposal | Against | For |
| June 2, 2026 | General Motors Company | Shareholder Proposal Regarding Separation of Chair and CEO Roles Shareholder proposal | Against | For |
| June 2, 2026 | General Motors Company | Shareholder Proposal Requesting a Report on Human Rights Standards for Indigenous Peoples Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | For | Against |
| April 22, 2026 | The Cigna Group | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposal | For | Against |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| April 1, 2026 | Hewlett Packard Enterprise Company | Stockholder proposal entitled: "Report on Discrimination in Charitable Support" Shareholder proposal | Against | For |
| May 14, 2026 | Ford Motor Company | A shareholder proposal relating to a request that the Board take steps to implement one vote per share for all outstanding shares. Shareholder proposal | For | Against |
1,703 ballot items at 125 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Invesco S&P 500 (R) Pure Value ETF (RPV) voted at 125 shareholder meetings of 120 companies, on 1,703 ballot items in all. Where management made a recommendation, the fund followed it on 94.5% of the items and voted against it 79 times. Its most frequent area of disagreement was corporate governance (44 of its votes against management). It voted FOR 31.6% of the 79 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Invesco's funds as a whole (98.2% against 94.5%). It voted the same way as most Invesco funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Invesco’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.